EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of Biological Rhythms in New Drug Formulations to Cross the Brain Barriers

Rafael Mineiro, Tânia Albuquerque, Ana Raquel Neves, Cecília R A Santos iD, Diana Costa iD, Telma Quintela iD

International Journal of Molecular Sciences · 08.08.2023 · 24 (16) · 12541

DOI: 10.3390/ijms241612541 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 08.08.2023. Verfasst von Rafael Mineiro und 5 weiteren Autor:innen. Beteiligte Einrichtung: CICS-UBI-Health Sciences Research Centre, Universidade da Beira Interior, Avenida Infante D. Henrique, 6200-506 Covilhã, Portugal. Hauptthemen laut MEDLINE: Brain, Head. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 188 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Portuguese FCT/MCTES.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

For brain protection, the blood–brain barrier and blood–cerebrospinal fluid barrier limit the traffic of molecules between blood and brain tissue and between blood and cerebrospinal fluid, respectively. Besides their protective function, brain barriers also limit the passage of therapeutic drugs to the brain, which constitutes a great challenge for the development of therapeutic strategies for brain disorders. This problem has led to the emergence of novel strategies to treat neurological disorders, like the development of nanoformulations to deliver therapeutic agents to the brain. Recently, functional molecular clocks have been identified in the blood–brain barrier and in the blood–cerebrospinal fluid barrier. In fact, circadian rhythms in physiological functions related to drug disposition were also described in brain barriers. This opens the possibility for chronobiological approaches that aim to use time to improve drug efficacy and safety. The conjugation of nanoformulations with chronobiology for neurological disorders is still unexplored. Facing this, here, we reviewed the circadian rhythms in brain barriers, the nanoformulations studied to deliver drugs to the brain, and the nanoformulations with the potential to be conjugated with a chronobiological approach to therapeutic strategies for the brain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrainHeadDrug CompoundingBlood-Brain BarrierCircadian Rhythm

Stichwörter der Autor:innen

blood–brain barrierblood–cerebrospinal fluid barriercircadian rhythmsexosomesliposomesnanoformulationsnanoparticlesnanotubes

Autor:innen und Institutionen

  • CICS-UBI-Health Sciences Research Centre, Universidade da Beira Interior, Avenida Infante D. Henrique, 6200-506 Covilhã, Portugal.
  • UDI-IPG-Unidade de Investigação para o Desenvolvimento do Interior, Instituto Politécnico da Guarda, 6300-559 Guarda, Portugal.

ORCID-Profile: Cecília R A Santos, Diana Costa, Telma Quintela

Förderung

  • Portuguese FCT/MCTES

Zitieren

APA

Mineiro, R., Albuquerque, T., Neves, A. R., Santos, C. R. A., Costa, D., & Quintela, T. (2023). The Role of Biological Rhythms in New Drug Formulations to Cross the Brain Barriers. International Journal of Molecular Sciences, 24(16), 12541. https://doi.org/10.3390/ijms241612541

Vancouver

Mineiro R, Albuquerque T, Neves AR, Santos CRA, Costa D, Quintela T. The Role of Biological Rhythms in New Drug Formulations to Cross the Brain Barriers. International Journal of Molecular Sciences. 2023;24(16):12541. doi:10.3390/ijms241612541

BibTeX
@article{Mineiro2023,
  author = {Mineiro, Rafael and Albuquerque, Tânia and Neves, Ana Raquel and Santos, Cecília R A and Costa, Diana and Quintela, Telma},
  title = {The Role of Biological Rhythms in New Drug Formulations to Cross the Brain Barriers},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {16},
  pages = {12541},
  doi = {10.3390/ijms241612541}
}
Kostenlos starten →